Skip to main content

New Frontiers in Immunotherapy

Buy Article:

$39.50 plus tax (Refund Policy)

Abstract:

Traditional allergen immunotherapy has been shown to be effective in numerous studies and can affect the natural course of allergic diseases. However, knowledge gained from cytokine regulation and vaccines as immuno-modifiers have shed new insight into other forms of immunotherapy. Novel routes, the role of allergen vaccines, and humanized anti-IgE and DNA-based immunization are the new frontiers of immunotherapy. This review considers both humoral and cellular response, mechanisms, and investigations at our center and the role of anti-IgE-based immunization as other strategies.

Document Type: Research Article

DOI: https://doi.org/10.2500/108854199778251988

Publication date: 1999-09-01

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • www.AJRA.com
  • www.AllergyandRhinology.com
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more